We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
-3.26%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.39B
AUM Growth
-$185M
Cap. Flow
-$115M
Cap. Flow %
-8.24%
Top 10 Hldgs %
27.7%
Holding
1,055
New
41
Increased
205
Reduced
674
Closed
134

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$734K
2
SMAR
Smartsheet Inc.
SMAR
+$733K
3
AR icon
Antero Resources
AR
+$530K
4
PDCE
PDC Energy, Inc.
PDCE
+$496K
5
HR icon
Healthcare Realty
HR
+$469K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$6.23M
2
MSFT icon
Microsoft
MSFT
+$4.32M
3
CVX icon
Chevron
CVX
+$3.81M
4
XOM icon
ExxonMobil
XOM
+$3.28M
5
AMZN icon
Amazon
AMZN
+$2.4M

Sector Composition

Rank Sector Weight
1 Technology 29.23%
2 Healthcare 18.87%
3 Consumer Discretionary 11.33%
4 Communication Services 9.29%
5 Energy 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDA icon
451
Idacorp
IDA
$8.23B
$404K 0.03%
4,077
-209
-5% -$22.8K
ARE icon
452
Alexandria Real Estate Equities
ARE
$8.88B
$403K 0.03%
2,872
-417
-13% -$64K
ELAN icon
453
Elanco Animal Health
ELAN
$12.4B
$403K 0.03%
32,511
-4,259
-12% -$74.4K
RELX icon
454
RELX
RELX
$60.1B
$403K 0.03%
16,575
-1,862
-10% -$50.6K
ENTG icon
455
Entegris
ENTG
$19.7B
$402K 0.03%
4,846
+15
+0.3% +$1.47K
GTLS
456
DELISTED
Chart Industries
GTLS
$401K 0.03%
2,174
+84
+4% +$15.6K
AJG icon
457
Arthur J. Gallagher & Co
AJG
$63.7B
$398K 0.03%
2,324
+56
+2% +$9.94K
DNLI icon
458
Denali Therapeutics
DNLI
$3.67B
$398K 0.03%
12,962
+186
+1% +$6.05K
CFR icon
459
Cullen/Frost Bankers
CFR
$10.3B
$397K 0.03%
3,000
+151
+5% +$19.8K
DAR icon
460
Darling Ingredients
DAR
$9.93B
$397K 0.03%
6,009
-172
-3% -$12K
OGS icon
461
ONE Gas
OGS
$5.05B
$397K 0.03%
5,640
-89
-2% -$7.17K
OPEN icon
462
Opendoor
OPEN
$3.69B
$394K 0.03%
130,754
+35,475
+37% +$163K
FITB
463
Fifth Third Bancorp
FITB
$52B
$393K 0.03%
12,282
-413
-3% -$14.2K
TXRH icon
464
Texas Roadhouse
TXRH
$12.7B
$393K 0.03%
4,509
-89
-2% -$7.76K
COF icon
465
Capital One
COF
$124B
$392K 0.03%
4,253
+6
+0.1% +$639
AIG icon
466
American International
AIG
$41.9B
$390K 0.03%
8,213
-243
-3% -$12.8K
GSK icon
467
GSK
GSK
$103B
$389K 0.03%
13,223
-1,524
-10% -$57.8K
NJR icon
468
New Jersey Resources
NJR
$6.06B
$389K 0.03%
10,042
-163
-2% -$7.27K
MSCI icon
469
MSCI
MSCI
$40B
$387K 0.03%
918
+31
+3% +$14.2K
SCI icon
470
Service Corp International
SCI
$11.4B
$386K 0.03%
6,684
-90
-1% -$5.93K
PCTY icon
471
Paylocity
PCTY
$6.71B
$385K 0.03%
1,593
+23
+1% +$5.28K
HR icon
472
Healthcare Realty
HR
$7.42B
$384K 0.03%
+18,438
New +$469K
INVH icon
473
Invitation Homes
INVH
$17.7B
$384K 0.03%
11,373
+1,229
+12% +$45.6K
EMR icon
474
Emerson Electric
EMR
$82.9B
$381K 0.03%
5,207
-7
-0.1% -$581
GGG icon
475
Graco
GGG
$12.9B
$381K 0.03%
6,354
-393
-6% -$25.2K
17 18
19
20 21

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Profund Advisors held 1,055 positions worth $1.39B, down 12% from $1.57B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Profund Advisors withdrew a net $115M in Q3 2022, closing 134 positions and reducing 674 holdings. Its most notable exit was CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES), an estimated $1.13M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Profund Advisors opened a new position in Apellis Pharmaceuticals worth $847K.

  • Profund Advisors's largest Q3 2022 buy was Apellis Pharmaceuticals: 12,407 shares worth $847K.
  • Profund Advisors added most to Annaly Capital Management in Q3 2022, an estimated $380K increase.
  • Profund Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $6.23M.
  • Profund Advisors fully exited CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES) in Q3 2022, selling an estimated $1.13M.
  • Profund Advisors's ten largest holdings make up 28% of its $1.39B portfolio in Q3 2022.
  • Profund Advisors opened 41 new positions and closed 134 in Q3 2022.
  • Profund Advisors's portfolio value fell 12% quarter-over-quarter to $1.39B.

Based on Profund Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.